微医在银川启动健康医疗大数据战略合作,透露赴港IPO计划不变

2019-06-22 佚名 医谷

6月21日,微医与银川市卫健委签署“互联网+医疗健康”战略合作协议,将以互联网、大数据、人工智能技术为驱动,探索建立基于数字化的健康共同体,打造银川互联网+医疗健康的2.0阶段。

作为全国互联网+医疗健康示范区,银川在全国已形成“互联网+医疗健康”创新服务的1.0示范效应。目前,银川市已落户30多家“互联网+医疗健康”相关企业,包括宁夏互联网医院、银川智慧互联网医院等在内的注册线上医生总数已达3万余名,累计服务患者达到了1300万余人次。此次与微医的合作,意在全国范围内开展一场互联网+医疗健康领域的全新探索,开放引入更多优质的医疗、技术和产业资源,建立基于数字化的健康共同体,通过政策、技术与机制的全面改革,探索以居民健康为中心的新医疗模式,这也是微医更进一步的参与国家健康医疗大数据产业。

微医集团董事长兼CEO廖杰远表示,希望双方在3年内以健康为中心,建成以居民电子健康档案、电子病历、电子处方等为核心的基础数据库,建设银川市人口健康信息平台,在银川组成医疗技术联盟、药械联盟和创新服务联盟,让创新服务贯穿市、县、乡、村四级,医疗、医药、医保、医教、医养联动改革效应显现,加速银川“互联网+医疗健康”2.0产业集聚效应。


微医集团董事长兼CEO廖杰远

银川市卫生健康委主任马晓飞表示,银川将继续发挥宁夏“互联网+医疗健康”示范区、银川“互联网+医疗健康”产业园的先发优势,盘活全市医疗卫生资源,通过构建开放的“互联网+医疗健康”生态体系,加快推进全市人口健康信息化、智慧医养、家庭医生签约、标准化专科诊疗体系等平台建设,率先建成具有行业示范效应的数字化健共体。


银川市卫生健康委主任马晓飞讲话

在活动当天的采访中廖杰远表示,微医核心聚焦政府、行业、消费三大业务线,实现服务和用户规模的快速增长。他还表示,微医主体在港IPO的计划没有变化,持续看好港交所在生物医药、数字医疗等领域的发展空间,并与港交所保持常态沟通。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1736004, encodeId=fdc11e3600437, content=<a href='/topic/show?id=21be3492589' target=_blank style='color:#2F92EE;'>#医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34925, encryptionId=21be3492589, topicName=医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0ea34047589, createdName=aids224, createdTime=Tue Mar 31 19:49:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046010, encodeId=4313204601039, content=<a href='/topic/show?id=2cc92e76464' target=_blank style='color:#2F92EE;'>#健康医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27764, encryptionId=2cc92e76464, topicName=健康医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a124, createdName=muzishouyi, createdTime=Sat Dec 07 03:49:00 CST 2019, time=2019-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677623, encodeId=ffd416e762347, content=<a href='/topic/show?id=51162e76305' target=_blank style='color:#2F92EE;'>#健康医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27763, encryptionId=51162e76305, topicName=健康医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2fd27558420, createdName=jiadan198791, createdTime=Fri Jan 17 05:49:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478249, encodeId=08c514e82491f, content=<a href='/topic/show?id=5e295415950' target=_blank style='color:#2F92EE;'>#战略合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54159, encryptionId=5e295415950, topicName=战略合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba6c7422782, createdName=ms8435843352634314, createdTime=Mon Jun 24 13:49:00 CST 2019, time=2019-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510838, encodeId=0dea1510838ab, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10002, encryptionId=f98210002a8, topicName=IPO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a1910256881, createdName=dzx0922892, createdTime=Mon Jun 24 13:49:00 CST 2019, time=2019-06-24, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1736004, encodeId=fdc11e3600437, content=<a href='/topic/show?id=21be3492589' target=_blank style='color:#2F92EE;'>#医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34925, encryptionId=21be3492589, topicName=医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0ea34047589, createdName=aids224, createdTime=Tue Mar 31 19:49:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046010, encodeId=4313204601039, content=<a href='/topic/show?id=2cc92e76464' target=_blank style='color:#2F92EE;'>#健康医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27764, encryptionId=2cc92e76464, topicName=健康医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a124, createdName=muzishouyi, createdTime=Sat Dec 07 03:49:00 CST 2019, time=2019-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677623, encodeId=ffd416e762347, content=<a href='/topic/show?id=51162e76305' target=_blank style='color:#2F92EE;'>#健康医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27763, encryptionId=51162e76305, topicName=健康医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2fd27558420, createdName=jiadan198791, createdTime=Fri Jan 17 05:49:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478249, encodeId=08c514e82491f, content=<a href='/topic/show?id=5e295415950' target=_blank style='color:#2F92EE;'>#战略合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54159, encryptionId=5e295415950, topicName=战略合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba6c7422782, createdName=ms8435843352634314, createdTime=Mon Jun 24 13:49:00 CST 2019, time=2019-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510838, encodeId=0dea1510838ab, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10002, encryptionId=f98210002a8, topicName=IPO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a1910256881, createdName=dzx0922892, createdTime=Mon Jun 24 13:49:00 CST 2019, time=2019-06-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1736004, encodeId=fdc11e3600437, content=<a href='/topic/show?id=21be3492589' target=_blank style='color:#2F92EE;'>#医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34925, encryptionId=21be3492589, topicName=医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0ea34047589, createdName=aids224, createdTime=Tue Mar 31 19:49:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046010, encodeId=4313204601039, content=<a href='/topic/show?id=2cc92e76464' target=_blank style='color:#2F92EE;'>#健康医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27764, encryptionId=2cc92e76464, topicName=健康医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a124, createdName=muzishouyi, createdTime=Sat Dec 07 03:49:00 CST 2019, time=2019-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677623, encodeId=ffd416e762347, content=<a href='/topic/show?id=51162e76305' target=_blank style='color:#2F92EE;'>#健康医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27763, encryptionId=51162e76305, topicName=健康医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2fd27558420, createdName=jiadan198791, createdTime=Fri Jan 17 05:49:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478249, encodeId=08c514e82491f, content=<a href='/topic/show?id=5e295415950' target=_blank style='color:#2F92EE;'>#战略合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54159, encryptionId=5e295415950, topicName=战略合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba6c7422782, createdName=ms8435843352634314, createdTime=Mon Jun 24 13:49:00 CST 2019, time=2019-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510838, encodeId=0dea1510838ab, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10002, encryptionId=f98210002a8, topicName=IPO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a1910256881, createdName=dzx0922892, createdTime=Mon Jun 24 13:49:00 CST 2019, time=2019-06-24, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1736004, encodeId=fdc11e3600437, content=<a href='/topic/show?id=21be3492589' target=_blank style='color:#2F92EE;'>#医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34925, encryptionId=21be3492589, topicName=医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0ea34047589, createdName=aids224, createdTime=Tue Mar 31 19:49:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046010, encodeId=4313204601039, content=<a href='/topic/show?id=2cc92e76464' target=_blank style='color:#2F92EE;'>#健康医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27764, encryptionId=2cc92e76464, topicName=健康医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a124, createdName=muzishouyi, createdTime=Sat Dec 07 03:49:00 CST 2019, time=2019-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677623, encodeId=ffd416e762347, content=<a href='/topic/show?id=51162e76305' target=_blank style='color:#2F92EE;'>#健康医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27763, encryptionId=51162e76305, topicName=健康医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2fd27558420, createdName=jiadan198791, createdTime=Fri Jan 17 05:49:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478249, encodeId=08c514e82491f, content=<a href='/topic/show?id=5e295415950' target=_blank style='color:#2F92EE;'>#战略合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54159, encryptionId=5e295415950, topicName=战略合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba6c7422782, createdName=ms8435843352634314, createdTime=Mon Jun 24 13:49:00 CST 2019, time=2019-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510838, encodeId=0dea1510838ab, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10002, encryptionId=f98210002a8, topicName=IPO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a1910256881, createdName=dzx0922892, createdTime=Mon Jun 24 13:49:00 CST 2019, time=2019-06-24, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1736004, encodeId=fdc11e3600437, content=<a href='/topic/show?id=21be3492589' target=_blank style='color:#2F92EE;'>#医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34925, encryptionId=21be3492589, topicName=医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0ea34047589, createdName=aids224, createdTime=Tue Mar 31 19:49:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046010, encodeId=4313204601039, content=<a href='/topic/show?id=2cc92e76464' target=_blank style='color:#2F92EE;'>#健康医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27764, encryptionId=2cc92e76464, topicName=健康医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a124, createdName=muzishouyi, createdTime=Sat Dec 07 03:49:00 CST 2019, time=2019-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677623, encodeId=ffd416e762347, content=<a href='/topic/show?id=51162e76305' target=_blank style='color:#2F92EE;'>#健康医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27763, encryptionId=51162e76305, topicName=健康医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2fd27558420, createdName=jiadan198791, createdTime=Fri Jan 17 05:49:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478249, encodeId=08c514e82491f, content=<a href='/topic/show?id=5e295415950' target=_blank style='color:#2F92EE;'>#战略合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54159, encryptionId=5e295415950, topicName=战略合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba6c7422782, createdName=ms8435843352634314, createdTime=Mon Jun 24 13:49:00 CST 2019, time=2019-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510838, encodeId=0dea1510838ab, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10002, encryptionId=f98210002a8, topicName=IPO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a1910256881, createdName=dzx0922892, createdTime=Mon Jun 24 13:49:00 CST 2019, time=2019-06-24, status=1, ipAttribution=)]
    2019-06-24 dzx0922892

相关资讯

医联体规模疯狂扩张 专科建设已超过20种

全国各地各级机关颁布了很多政策,各等级医院也纷纷响应,医联体模式也比以前更多,专科医联体的搭建也超过20多种。

哈佛公卫学院携微医以大数据助力健康中国

哈佛公卫学院与微医在中国开展试点,探索医疗卫生服务体系等工作。

积聚七年之力 微医打造家庭医疗服务体系

以“基地+网点+终端”为架构,微医发布家庭医疗服务体系,向亿万家庭输送便捷、主动、全程的家庭医疗服务,一站式满足用户在健康管理、医疗服务、健康消费和健康保险在内的全方位需求。

国内健康电商平台上线 微医严选力推专病随访服务

日前,微医正式推出自有健康电商品牌“微医严选”,属国内首个真正意义上的健康电商平台。

挂号网发布“微医”,涉足医患全流程,标志互联网+医疗提速

“医学发展如何借力高科技?互联网如何助力医疗?”2015年3月28日,中华医学杂志创刊100周年暨高科技医学发展与互联网医疗高峰论坛在上海召开。来自多位两院院士、知名医院院长、行业顶级专家等350余人,就医学最新前沿和互联网医疗进行了深入的探讨。此次会议与以往不同的是,是中国医疗界首次将互联网医疗与高科技医学作为会议主题,进行深度的跨界思想交流。挂号网---作为唯一一家受邀参加此次盛会的互联网医疗

技术驱动变革 微医“四驾马车”驰入医疗圈

微医发布“微医云、微医疗、微医药、微医险”四大业务平台,行业布局脉络渐渐清晰……